Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta

B M Forman1, I Tzameli, H S Choi

  • 1The City of Hope National Medical Center, Duarte, California 91010, USA. bforman@gte.net

Nature
|October 23, 1998
PubMed

Insights

Constitutive Androstane Receptor-beta (CAR-beta) activity is inhibited by specific androstane steroids. These steroids act as inverse agonists, reversing CAR-beta

Area of Science:

  • Molecular Endocrinology
  • Steroid Signaling Pathways
  • Nuclear Receptor Research

Background:

  • The orphan receptor CAR-beta (constitutive androstane receptor-beta) forms heterodimers with the retinoid-X receptor.
  • CAR-beta constitutively activates gene transcription independently of ligand binding.
  • Classical nuclear receptors typically require ligand binding for transcriptional activation.

Purpose of the Study:

  • To investigate the mechanism behind CAR-beta's constitutive activity.
  • To identify potential ligands that modulate CAR-beta activity.
  • To characterize the nature of identified ligands and their mechanism of action.

Main Methods:

  • Screening for potential ligands of CAR-beta.
  • Assessing the effect of identified steroids on CAR-beta's constitutive transcriptional activity.
  • Evaluating the stereospecificity of the steroid interaction.
  • Analyzing the impact of steroids on CAR-beta heterodimerization, DNA binding, and co-activator recruitment/release.

Main Results:

  • Androstanol and androstenol were identified as inhibitors of CAR-beta's constitutive activity.
  • The inhibitory effect was stereospecific, requiring a 3alpha-hydroxy, 5alpha-reduced androstane structure.
  • These androstanes do not affect heterodimerization or DNA binding but promote co-activator release from CAR-beta.

Conclusions:

  • CAR-beta functions via ligand-independent co-activator recruitment.
  • Specific androstanes act as naturally occurring inverse agonists for CAR-beta.
  • This defines a novel steroidal signaling pathway opposing conventional nuclear receptor mechanisms.

Related Concept Videos

Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
Types of Receptors: Internal Receptors01:07

Types of Receptors: Internal Receptors

Many cellular signals are hydrophilic and cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind intracellular receptors that reside within the cell cytoplasm or nucleus. Many mammalian steroid hormones and nitric oxide (NO) gas use this cell signaling mechanism.
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...